1063331-94-1

Basic information

• Product Name: N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine
• Synonyms: N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine;NS13001
• CAS NO: 1063331-94-1
• Molecular Formula: C₁₇H₁₆ClN₇
• Molecular Weight: 353.80884
• Mol File: 1063331-94-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine(1063331-94-1)
• EPA Substance Registry System: N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine(1063331-94-1)

Safety Data

• Hazardous Substances Data: 1063331-94-1(Hazardous Substances Data)

Usage

Uses

N-(4-Chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)-9-methyl-9H-purin-6-amine (CAS# 1063331-94-1) is a selective positive modulator of calcium-activated potassium channels which exhibits beneficial effects in a mouse model of spinocerebellar ataxia type 2.

Upstream product

• 5451-40-1 2,6 dichloropurine 
• 2382-10-7 2,6-dichloro-9-methyl-9H-purine 
• 1062592-41-9 (2-chloro-9-methyl-9H-purin-6-yl)-(4-chloro-phenyl)-amine 
• 2617-79-0 N-(4-chlorophenyl)formamide 
• 106-47-8 4-chloro-aniline 
• 1062592-48-6 (4-chloro-phenyl)-(2-hydrazino-9-methyl-9H-purin-6-yl)-amine 
• 123-54-6 acetylacetone 
• 67-51-6 3,5-dimethyl-1H-pyrazole 

Downstream Products

• 1063332-92-2 (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-amine sulfate 
• 1063332-93-3 (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-amine hydrochloride 
• 1063332-95-5 (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-amine hydrobromide 
• 1219139-21-5 (4-chloro-phenyl)-[2-(3,5-dimethyl-pyrazol-1-yl)-9-methyl-9H-purin-6-yl]-carbamic acid 2-methoxy-ethyl ester 

Relevant articles and documents

SUBSTITUTED PURINYL-PYRAZOL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS

This invention relates to novel substituted purinyl-pyrazol derivatives of formula (I) and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of disea

PURINYL DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS

This invention relates to novel purinyl derivatives and their use as potassium channel modulating agents. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels.